 |
인쇄하기
취소
|
Hanmi and SK will develop generics of Xarelto
It is observed that the generic of the 2nd generation anticoagulant ‘Xarelto’ is being developed.
It is known that the owner company of ‘Xarelto’, Bayer Korea, acquired an approval for the bioequivalence test plan to develop the generic.
According to the Ministiry of Food and Drug Safety, SK Chemical recently acquired an approval for the bioequivalence test planon rivaroxaban 20mg and 2.5mg.
...Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.